Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;28(5):3199-3214.
doi: 10.1007/s11030-023-10747-y. Epub 2023 Oct 27.

Design anticancer potential of Zn(II)isoleucinedithiocarbamate complex on MCF-7 cell lines: synthesis, characterization, molecular docking, molecular dynamic, ADMET, and in-vitro studies

Rizal Irfandi  1   2 , Indah Raya  3 , Ahyar Ahmad  4 , Ahmad Fudholi  5   6 , Riswandi  4 , Santi Santi  7 , Wynda Puspa Azalea  8 , Suriati Eka Putri  9 , Muhammad Nur Alam  1 , Unang Supratman  10 , Samuel Olawale Olubode  11 , Eid A Abdalrazaq  12 , Mahmoud Kandeel  13 , Nunuk Hariani Soekamto  4 , Hasnah Natsir  4 , Maming  4 , Ramlawati  14
Affiliations

Design anticancer potential of Zn(II)isoleucinedithiocarbamate complex on MCF-7 cell lines: synthesis, characterization, molecular docking, molecular dynamic, ADMET, and in-vitro studies

Rizal Irfandi et al. Mol Divers. 2024 Oct.

Abstract

Cisplatin is a cancer medication widely used today, but it still poses some problems due to its toxic properties in the body. To overcome this issue, a new complex has been developed as a potential anticancer drug prospect by minimizing its toxic consequences. A novel Zn(II)IleDTC complex containing isoleucine dithiocarbamate ligands has been produced and analyzed using a range of analytical and spectroscopic methods. The Zn(II) IleDTC complex were characterized using various methods, including UV-Vis spectroscopy, FT-IR, determination of melting point, conductivity, and HOMO-LUMO analysis. Furthermore, computational NMR spectrum analysis was conducted in this study. Molecular docking studies was conducted to evaluate the potential of Zn(II) isoleucine dithiocarbamate as an HIF1 inhibitor. The results showed that the Zn complex exhibited a good docking score of -6.6 and formed hydrogen bonds with ARG 17, VAL264, and GLU15, alkyl bonds with TRP27 and LEU32, and Pi-Alkyl bonds with PRO41 and ARG44. This suggests that the Zn(II) isoleucine dithiocarbamate complex could be a promising candidate for cancer treatment with potential HIF1 inhibition properties. To assess the dynamic stability and efficacy of protein-ligand interactions over time, molecular dynamics simulations was conducted for both individual proteins and protein complexes. The cytotoxicity evaluation of Zn(II) isoleucine dithiocarbamate against MCF-7 cells obtained an IC50 value of 362.70 µg/mL indicating moderate cytotoxicity and morphological changes of cancer cells causing cancer cells to undergo apoptosis. The Zn(II) isoleucine dithiocarbamate complex may have promising potential as an anticancer compound due to its significant inhibitory effect on the breast cancer cell line (MCF7). According to the ADMET study, the complex exhibits drug-like characteristics with low toxicity, further supporting its potential as a viable drug candidate.

Keywords: ADMET; Cancer; Dithiocarbamate; In-vitro; Isoleucine; Zn(II).

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Conflict of interest: No conflict of interest is declared by the writers.

References

    1. Momenimovahed Z, Ghoncheh M, Pakzad R, Hasanpour H, Salehiniya H (2017) Incidence and mortality of uterine cancer and relationship with Human Development Index in the world. Cukurova Med J 42(2):233–40 - DOI
    1. Momenimovahed Z, Salehiniya H (2017) Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther 4(12):1795–811 - DOI
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209 - DOI - PubMed
    1. Youlden DR, Cramb SM, Yip CH, Baade PD (2014) Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 11(2):101–115 - PubMed - PMC
    1. Ghoncheh M, Pournamdar Z, Salehiniya H (2016) Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev 17(S3):43–6 - DOI - PubMed

MeSH terms

LinkOut - more resources